ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,704
Screening encounters
4,331
Diagnostic referrals
828
Outstanding pathways
304

Screening pathway

  1. Screening4,331Encounters
  2. Positive finding1,491Documented findings
  3. Referral828Diagnostic referrals
  4. Follow-up973Diagnostic visits
  5. Outcome524Resolved pathways

Stage totals use different units. Pending pathways: 304. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3232 · EXP-3232Synthetic · Site B

Full participant history through 2026-10-23, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-03-20
  4. · Diagnostic referral · EXP-3232-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Contact attempt · Reached
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-3232-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-02-20

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3704 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3045 · Expanded synthetic participant 3045Site D — Community Engagement Programme
EXP-3046 · Expanded synthetic participant 3046Site E — Resource-Constrained Navigation Programme
EXP-3047 · Expanded synthetic participant 3047Site B — Peri-Urban Access Programme
EXP-3049 · Expanded synthetic participant 3049Site D — Community Engagement Programme
EXP-3052 · Expanded synthetic participant 3052Site E — Resource-Constrained Navigation Programme
EXP-3053 · Expanded synthetic participant 3053Site D — Community Engagement Programme
EXP-3054 · Expanded synthetic participant 3054Site C — Rural Outreach Programme
EXP-3055 · Expanded synthetic participant 3055Site C — Rural Outreach Programme
EXP-3056 · Expanded synthetic participant 3056Site D — Community Engagement Programme
EXP-3057 · Expanded synthetic participant 3057Site D — Community Engagement Programme
EXP-3058 · Expanded synthetic participant 3058Site A — Urban Referral Hub
EXP-3059 · Expanded synthetic participant 3059Site C — Rural Outreach Programme
EXP-3060 · Expanded synthetic participant 3060Site A — Urban Referral Hub
EXP-3062 · Expanded synthetic participant 3062Site E — Resource-Constrained Navigation Programme
EXP-3063 · Expanded synthetic participant 3063Site E — Resource-Constrained Navigation Programme
EXP-3066 · Expanded synthetic participant 3066Site E — Resource-Constrained Navigation Programme
EXP-3068 · Expanded synthetic participant 3068Site E — Resource-Constrained Navigation Programme
EXP-3069 · Expanded synthetic participant 3069Site B — Peri-Urban Access Programme
EXP-3070 · Expanded synthetic participant 3070Site C — Rural Outreach Programme
EXP-3071 · Expanded synthetic participant 3071Site D — Community Engagement Programme
EXP-3072 · Expanded synthetic participant 3072Site B — Peri-Urban Access Programme
EXP-3073 · Expanded synthetic participant 3073Site B — Peri-Urban Access Programme
EXP-3074 · Expanded synthetic participant 3074Site D — Community Engagement Programme
EXP-3076 · Expanded synthetic participant 3076Site A — Urban Referral Hub
EXP-3079 · Expanded synthetic participant 3079Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1681
HPV DNA
2042
Cytology
608

Navigation activity

Barrier documented
733
Contact attempt
1215
Navigation intervention
311
Diagnostic booking
1031
Diagnostic visit
973

Documented barriers

Contact difficulty
236
Transport difficulty
239
Appointment coordination
258

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.